|
1
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar
|
|
2
|
Fu OY, Hou MF, Yang SF, Huang SC and Lee
WY: Cobalt chloride-induced hypoxia modulates the invasive
potential and matrix metalloproteinases of primary and metastatic
breast cancer cells. Anticancer Res. 29:3131–3138. 2009.PubMed/NCBI
|
|
3
|
Geng J, Fan J, Ouyang Q, Zhang X, Zhang X,
Yu J, Xu Z, Li Q, Yao X, Liu X, et al: Loss of PPM1A expression
enhances invasion and the epithelial-to-mesenchymal transition in
bladder cancer by activating the TGF-β/Smad signaling pathway.
Oncotarget. 5:5700–5711. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Balamurugan K: HIF-1 at the crossroads of
hypoxia, inflammation, and cancer. Int J Cancer. Mar 17–2015.Epub
ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu H, Luo SF, Wang J, Li X, Wang H, Pu
WY, Zhang H and Zhuang ZX: Effect of environmental factors on
chemoresistance of HepG2 cells by regulating hypoxia-inducible
factor-1α. Chin Med J (Engl). 125:1095–1103. 2012.
|
|
6
|
Semenza GL: Oxygen sensing,
hypoxia-inducible factors, and disease pathophysiology. Annu Rev
Pathol. 9:47–71. 2014. View Article : Google Scholar
|
|
7
|
Wenger RH, Stiehl DP and Camenisch G:
Integration of oxygen signaling at the consensus HRE. Sci STKE.
2005:re122005.PubMed/NCBI
|
|
8
|
Swietach P, Hulikova A, Vaughan-Jones RD
and Harris AL: New insights into the physiological role of carbonic
anhydrase IX in tumour pH regulation. Oncogene. 29:6509–6521. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ilardi G, Zambrano N, Merolla F, Siano M,
Varricchio S, Vecchione M, De Rosa G, Mascolo M and Staibano S:
Histopathological determinants of tumor resistance: A special look
to the immunohistochemical expression of carbonic anhydrase IX in
human cancers. Curr Med Chem. 21:1569–1582. 2014. View Article : Google Scholar :
|
|
10
|
Shin HJ, Rho SB, Jung DC, Han IO, Oh ES
and Kim JY: Carbonic anhydrase IX (CA9) modulates tumor-associated
cell migration and invasion. J Cell Sci. 124:1077–1087. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Svastová E, Žilka N, Zat'ovicová M,
Gibadulinová A, Čiampor F, Pastorek J and Pastoreková S: Carbonic
anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via
interaction with beta-catenin. Exp Cell Res. 290:332–345. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen CL, Chu JS, Su WC, Huang SC and Lee
WY: Hypoxia and metabolic phenotypes during breast carcinogenesis:
Expression of HIF-1alpha, GLUT1, and CAIX. Virchows Arch.
457:53–61. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Choi J, Jung WH and Koo JS:
Metabolism-related proteins are differentially expressed according
to the molecular subtype of invasive breast cancer defined by
surrogate immunohistochemistry. Pathobiology. 80:41–52. 2013.
View Article : Google Scholar
|
|
14
|
Kwon JE, Jung WH and Koo JS: The
expression of metabolismrelated proteins in phyllodes tumors.
Tumour Biol. 34:115–124. 2013. View Article : Google Scholar
|
|
15
|
McDonald PC, Winum JY, Supuran CT and
Dedhar S: Recent developments in targeting carbonic anhydrase IX
for cancer therapeutics. Oncotarget. 3:84–97. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Swietach P, Patiar S, Supuran CT, Harris
AL and Vaughan-Jones RD: The role of carbonic anhydrase 9 in
regulating extracellular and intracellular ph in three-dimensional
tumor cell growths. J Biol Chem. 284:20299–20310. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Parks SK, Chiche J and Pouysségur J: pH
control mechanisms of tumor survival and growth. J Cell Physiol.
226:299–308. 2011. View Article : Google Scholar
|
|
18
|
Byrne MB, Leslie MT, Gaskins HR and Kenis
PJA: Methods to study the tumor microenvironment under controlled
oxygen conditions. Trends Biotechnol. 32:556–563. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu D and Yotnda P: Induction and testing
of hypoxia in cell culture. J Vis Exp. 54:e28992011.
|
|
20
|
Shweta, Mishra KP, Chanda S, Singh SB and
Ganju L: A comparative immunological analysis of CoCl2
treated cells with in vitro hypoxic exposure. Biometals.
28:175–185. 2015. View Article : Google Scholar
|
|
21
|
Dai ZJ, Gao J, Ma XB, Yan K, Liu XX, Kang
HF, Ji ZZ, Guan HT and Wang XJ: Up-regulation of hypoxia inducible
factor-1α by cobalt chloride correlates with proliferation and
apoptosis in PC-2 cells. J Exp Clin Cancer Res. 31:282012.
View Article : Google Scholar
|
|
22
|
Hunakova L, Sedlakova O, Cholujova D,
Gronesova P, Duraj J and Sedlak J: Modulation of markers associated
with aggressive phenotype in MDA-MB-231 breast carcinoma cells by
sulforaphane. Neoplasma. 56:548–556. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bartusik D, Tomanek B, Lattová E,
Perreault H and Fallone G: Combined treatment of human MCF-7 breast
carcinoma with antibody, cationic lipid and hyaluronic acid using
ex vivo assays. J Pharm Biomed Anal. 51:192–201. 2010. View Article : Google Scholar
|
|
24
|
Böcker W: WHO classification of breast
tumors and tumors of the female genital organs: Pathology and
genetics. Verh Dtsch Ges Pathol. 86:116–119. 2002.In German.
|
|
25
|
Allred DC, Wu Y, Mao S, Nagtegaal ID, Lee
S, Perou CM, Mohsin SK, O'Connell P, Tsimelzon A and Medina D:
Ductal carcinoma in situ and the emergence of diversity during
breast cancer evolution. Clin Cancer Res. 14:370–378. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tan EY, Campo L, Han C, Turley H, Pezzella
F, Gatter KC, Harris AL and Fox SB: Cytoplasmic location of
factor-inhibiting hypoxia-inducible factor is associated with an
enhanced hypoxic response and a shorter survival in invasive breast
cancer. Breast Cancer Res. 9:R892007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Goonewardene TI, Sowter HM and Harris AL:
Hypoxia-induced pathways in breast cancer. Microsc Res Tech.
59:41–48. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu Q, Xu Z, Mao S, Chen W, Zeng R, Zhou S
and Liu J: Effect of hypoxia on hypoxia inducible factor-1α,
insulin-like growth factor I and vascular endothelial growth factor
expression in hepatocellular carcinoma HepG2 cells. Oncol Lett.
9:1142–1148. 2015.PubMed/NCBI
|
|
29
|
Tomes L, Emberley E, Niu Y, Troup S,
Pastorek J, Strange K, Harris A and Watson PH: Necrosis and hypoxia
in invasive breast carcinoma. Breast Cancer Res Treat. 81:61–69.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Simonsen LO, Harbak H and Bennekou P:
Cobalt metabolism and toxicology - a brief update. Sci Total
Environ. 432:210–215. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tan EY, Yan M, Campo L, Han C, Takano E,
Turley H, Candiloro I, Pezzella F, Gatter KC, Millar EK, et al: The
key hypoxia regulated gene CAIX is upregulated in basal-like breast
tumours and is associated with resistance to chemotherapy. Br J
Cancer. 100:405–411. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bruckner BA, Ammini CV, Otal MP, Raizada
MK and Stacpoole PW: Regulation of brain glucose transporters by
glucose and oxygen deprivation. Metabolism. 48:422–431. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Thiry A, Dogné JM, Masereel B and Supuran
CT: Targeting tumor-associated carbonic anhydrase IX in cancer
therapy. Trends Pharmacol Sci. 27:566–573. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Colpaert CG, Vermeulen PB, Fox SB, Harris
AL, Dirix LY and Van Marck EA: The presence of a fibrotic focus in
invasive breast carcinoma correlates with the expression of
carbonic anhydrase IX and is a marker of hypoxia and poor
prognosis. Breast Cancer Res Treat. 81:137–147. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mitra S, Stemke-Hale K, Mills GB and
Claerhout S: Interactions between tumor cells and microenvironment
in breast cancer: A new opportunity for targeted therapy. Cancer
Sci. 103:400–407. 2012. View Article : Google Scholar
|
|
36
|
Li Y, Wang H, Oosterwijk E, Tu C,
Shiverick KT, Silverman DN and Frost SC: Expression and activity of
carbonic anhydrase IX is associated with metabolic dysfunction in
MDA-MB-231 breast cancer cells. Cancer Invest. 27:613–623. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Moellering RE, Black KC, Krishnamurty C,
Baggett BK, Stafford P, Rain M, Gatenby RA and Gillies RJ: Acid
treatment of melanoma cells selects for invasive phenotypes. Clin
Exp Metastasis. 25:411–425. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Estrella V, Chen T, Lloyd M, Wojtkowiak J,
Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg
JM, Sloane BF, et al: Acidity generated by the tumor
microenvironment drives local invasion. Cancer Res. 73:1524–1535.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim BR, Shin HJ, Kim JY, Byun HJ, Lee JH,
Sung YK and Rho SB: Dickkopf-1 (DKK-1) interrupts FAK/PI3K/mTOR
pathway by interaction of carbonic anhydrase IX (CA9) in
tumorigenesis. Cell Signal. 24:1406–1413. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Merdad A, Karim S, Schulten HJ, Dallol A,
Buhmeida A, Al-Thubaity F, Gari MA, Chaudhary AG, Abuzenadah AM and
Al-Qahtani MH: Expression of matrix metalloproteinases (MMPs) in
primary human breast cancer: MMP-9 as a potential biomarker for
cancer invasion and metastasis. Anticancer Res. 34:1355–1366.
2014.PubMed/NCBI
|
|
41
|
Mehner C, Hockla A, Miller E, Ran S,
Radisky DC and Radisky ES: Tumor cell-produced matrix
metalloproteinase 9 (MMP-9) drives malignant progression and
metastasis of basallike triple negative breast cancer. Oncotarget.
5:2736–2749. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bartosová M, Parkkila S, Pohlodek K,
Karttunen TJ, Galbavý S, Mucha V, Harris AL, Pastorek J and
Pastoreková S: Expression of carbonic anhydrase IX in breast is
associated with malignant tissues and is related to overexpression
of c-erbB2. J Pathol. 197:314–321. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Span PN, Bussink J, Manders P, Beex LV and
Sweep CG: Carbonic anhydrase-9 expression levels and prognosis in
human breast cancer: Association with treatment outcome. Br J
Cancer. 89:271–276. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Eom KY, Jang MH, Park SY, Kang EY, Kim SW,
Kim JH, Kim JS and Kim IA: The expression of carbonic anhydrase
(CA) IX/XII and lymph node metastasis in early breast cancer.
Cancer Res Treat. Mar 3–2015.Epub ahead of print. View Article : Google Scholar
|
|
45
|
Trastour C, Benizri E, Ettore F, Ramaioli
A, Chamorey E, Pouysségur J and Berra E: HIF-1α and CA IX staining
in invasive breast carcinomas: Prognosis and treatment outcome. Int
J Cancer. 120:1451–1458. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chia SK, Wykoff CC, Watson PH, Han C, Leek
RD, Pastorek J, Gatter KC, Ratcliffe P and Harris AL: Prognostic
significance of a novel hypoxia-regulated marker, carbonic
anhydrase IX, in invasive breast carcinoma. J Clin Oncol.
19:3660–3668. 2001.PubMed/NCBI
|
